+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
RAINBOW

Rainbow Childrens Medicare Share Price

 

 

Rainbow Childrens Medicare live price: ₹1470.8. It opened at ₹1,443 vs previous close ₹1,450; intraday high/low: ₹1,495/₹1,428. The 50 & 200 DMA stand at ₹1,327.40/₹1,309.79.

Rainbow Childrens Medicare Performance

  • Today's Low
  • ₹1,428
  • Today's High
  • ₹1,495
  • 52 Week Low
  • ₹1,084
  • 52 Week High
  • ₹1,646
  • Open Price₹1,443
  • Previous Close₹1,450
  • Volume216,444
  • 50 DMA₹1,327.40
  • 100 DMA₹1,299.07
  • 200 DMA₹1,309.79

Rainbow Childrens Medicare Chart

Investment Returns

  • Over 1 Month + 9.6%
  • Over 3 Month + 31.99%
  • Over 6 Month + 11.61%
  • Over 1 Year + 1.28%

Smart Investing Starts Here Start SIP with Rainbow Childrens Medicare for Steady Growth!

Invest Now

Rainbow Childrens Medicare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 53.7
  • PEG Ratio
  • 3.7
  • Market Cap Cr
  • 14,937
  • P/B Ratio
  • 9.1
  • Average True Range
  • 39.09
  • EPS
  • 27.52
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 26.57
  • RSI
  • 77.37
  • MFI
  • 76.47

Latest Stock News Updates

Broker's call: Rainbow Children's (Buy)

With newly commissioned capacities entering the ramp-up phase and occupancy levels expected to improve, we forecast Pre IND-AS EBITDA growth of 20% CAGR over FY26FY28E

Rainbow Children's Medicare aims to double revenue by FY30: Founder-Chairman Ramesh Kancharla

Rainbow Children's Medicare plans to double revenue by FY30, focusing on clinical excellence and patient experience, says Founder Ramesh Kancharla.

Q4FY26 & FY26 Result Announced for Rainbow Childrens Medicare Ltd.

Healthcare Facilities company Rainbow Childrens Medicare announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from operations: Reported at Rs 4,599.01 million for Q4FY26, an increase of 24.26% YoY (compared to Rs 3,701.07 million in Q4FY25) and an increase of 3.24% QoQ (compared to Rs 4,454.48 million in Q3FY26). For FY26, revenue was Rs 17,030.77 million, a YoY increase of 12.35% (compared to Rs 15,158.66 million in FY25). Profit after tax: Reported at Rs 782.18 million for Q4FY26, an increase of 38.31% YoY (compared to Rs 565.53 million in Q4FY25) and 5.85% QoQ (compared to Rs 738.97 million in Q3FY26). For FY26, profit after tax stood at Rs 2,815.44 million, a YoY increase of 15.28% (compared to Rs 2,442.27 million in FY25). Standalone Financial Highlights: Revenue from operations: Reported at Rs 4,080.64 million for Q4FY26, an increase of 15.27% YoY (compared to Rs 3,539.95 million in Q4FY25) and an increase of 3.48% QoQ (compared to Rs 3,943.52 million in Q3FY26). For FY26, revenue was Rs 15,456.60 million, a YoY increase of 6.27% (compared to Rs 14,545.06 million in FY25). Profit after tax: Reported at Rs 593.05 million for Q4FY26, an increase of 8.74% YoY (compared to Rs 545.40 million in Q4FY25) and a decrease of 9.90% QoQ (compared to Rs 658.24 million in Q3FY26). For FY26, profit after tax was Rs 2,500.16 million, a YoY increase of 5.23% (compared to Rs 2,375.83 million in FY25). Business Highlights: Dividend: The Board recommended a final dividend of Rs 3.5 per Equity Share (@ 35%) on a face value of Rs 10 per share for FY26, subject to approval at the 28th Annual General Meeting. The record date for the same is fixed for July 21, 2026. Acquisitions: The Company acquired a 76% equity stake and 100% of Non-Convertible Redeemable Preference shares of: M/s. Prashanthi Medicare Private Limited (Prashanthi Hospital) in July 2025. M/s. Pratiksha Women & Child Care Hospital Private Limited (Pratiksha Hospital) in August 2025. Regulatory Impact: Implementation of the "New Labour Codes" resulted in an increase of Rs 15.39 million in the provision for defined benefit obligation, which was recognized as an exceptional item in the statement of profit and loss. Re-appointments: The Board approved the re-appointment of Dr. Ramesh Kancharla as Chairman and Managing Director, Dr. Dinesh Kumar Chirla as Whole Time Director, Mr. Santanu Mukherjee as Independent Director, and Ms. Sundari R. Pisupati as Independent Director, each for a period of five years. Appointment of Cost Auditors: The Board approved the re-appointment of M/s. Lavanya & Associates LLP as Cost Auditors of the Company for FY27. Segment Information: The Company is engaged in a single business segment, viz., rendering medical and healthcare services, concentrated in India. Ramesh Kancharla, Chairman & Managing Director, Rainbow Children’s Medicare, said: “The quarter witnessed healthy momentum across the network, with key operating metrics showing steady growth and newer hospitals continuing to scale up well. Our recently launched HRBR hospital and Mahadevapura IVF Centre further strengthen Rainbow’s presence in key Bengaluru micro-markets and enhance access to integrated pediatric, obstetric, and fertility services. Mr. Abrar Ali Dalal has transitioned into the CEO role seamlessly and is leading operations, consultant engagement and execution across the network. With the current capacity expansion cycle largely complete, our focus is now firmly on execution — clinical excellence, improving occupancies, strengthening the service excellence and building sustainable growth across the group hospitals.” Result PDF

Rainbow Childrens Medicare Financials

Rainbow Childrens Medicare Technicals

EMA & SMA

Current Price
₹1,470.80
+ 20.8 (1.43%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,380.30
  • 50 Day
  • ₹1,327.40
  • 100 Day
  • ₹1,299.10
  • 200 Day
  • ₹1,309.80

Resistance and Support

1464.6 Pivot Speed
  • R3 1,568.20
  • R2 1,531.60
  • R1 1,501.20
  • S1 1,434.20
  • S2 1,397.60
  • S3 1,367.20

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Rainbow Children’s Medicare Ltd. is a leading pediatric healthcare provider in India, offering specialized medical services for children, including neonatal, pediatric, and maternity care. It operates a network of hospitals dedicated to child and maternal health.

Rainbow Children's Medicare has an operating revenue of Rs. 1,703.08 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 21% is great, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 11% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 74 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Rainbow Childrens Medicare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-23 Audited Results, Final Dividend & A.G.M.
2026-01-28 Quarterly Results
2025-11-13 Quarterly Results
2025-07-26 Quarterly Results
2025-05-24 Audited Results, Final Dividend & A.G.M.
Date Purpose Remarks
2026-07-21 FINAL Rs.3.50 per share(35%)Final Dividend
2025-06-28 FINAL Rs.3.00 per share(30%)Final Dividend
2024-07-23 FINAL Rs.3.00 per share(30%)Final Dividend
2023-06-22 FINAL Rs.3.00 per share(30%)Final Dividend
2022-09-08 FINAL Rs.2.00 per share(20%)Final Dividend
View Rainbow Childrens Medicare Dividend History Arrow

Rainbow Childrens Medicare Shareholding Pattern

49.84%
17.46%
1.97%
17.24%
10.7%
2.79%

Rainbow Childrens Medicare FAQs

Rainbow Childrens Medicare share price is ₹1,470 As on 21 June, 2026 | 15:10

The Market Cap of Rainbow Childrens Medicare is ₹14937.3 Cr As on 21 June, 2026 | 15:10

The P/E ratio of Rainbow Childrens Medicare is 53.7 As on 21 June, 2026 | 15:10

The PB ratio of Rainbow Childrens Medicare is 9.1 As on 21 June, 2026 | 15:10

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23